C83.46 Immunoblastic (diffuse) non-Hodgkin's lymphoma, intrapelvic lymph nodes

Name of the Condition

• Immunoblastic (diffuse) non-Hodgkin's lymphoma, intrapelvic lymph nodes
• Also known as ICD-10 code C83.46

Summary

Immunoblastic (diffuse) non-Hodgkin's lymphoma is a subtype of non-Hodgkin lymphoma characterized by the malignant proliferation of immunoblasts, a type of immature B-cell. It typically involves diffuse growth patterns in lymph nodes or other lymphoid tissues, with a tendency for rapid progression. This condition is part of the broader category of non-follicular lymphomas and may present with variable clinical behavior depending on the specific subtype.

Causes

The exact cause of immunoblastic (diffuse) non-Hodgkin's lymphoma remains unknown. It is thought to involve genetic mutations or abnormalities in B-cell development, though specific triggers are not well-defined. Research suggests potential links to immune system dysregulation or prior infections, but no definitive etiology has been established.

Risk Factors

• Age: More common in older adults.
• Family history of lymphoma.
• Prior exposure to radiation or certain chemicals.
• Chronic infections, such as hepatitis C or HIV.
• Immunosuppressive conditions or treatments.

Symptoms

• Swollen, painless lymph nodes.
• Unexplained weight loss.
• Fever.
• Night sweats.
• Fatigue.
• Loss of appetite.

Diagnosis

Diagnosis involves a combination of physical examination, imaging studies (e.g., CT or MRI) to assess lymph node involvement, and biopsy of affected tissue for histopathological analysis. Laboratory tests, including blood work and possibly bone marrow biopsy, may also be performed to evaluate disease extent and rule out other conditions.

Treatment Options

Treatment depends on the stage and aggressiveness of the lymphoma and may include chemotherapy, immunotherapy, targeted therapy, or radiation therapy. In some cases, stem cell transplantation or clinical trial participation may be considered. Treatment plans are individualized based on patient health and disease characteristics.

Prognosis and Follow-Up

Prognosis varies based on factors like disease stage, patient age, and overall health. Regular follow-up appointments, including imaging and blood tests, are essential to monitor for recurrence or progression. Long-term surveillance is typically recommended.

Complications

Potential complications include disease progression, treatment-related side effects (e.g., infection risk, organ toxicity), and secondary malignancies. Lymphoma may also spread to other organs or cause lymph node obstruction.

Lifestyle & Prevention

While specific prevention strategies are limited, maintaining a healthy immune system through balanced nutrition, regular exercise, and avoiding known risk factors (e.g., smoking, excessive alcohol) may support overall health. Early detection through prompt evaluation of symptoms is critical.

When to Seek Professional Help

Seek medical attention if you experience persistent swollen lymph nodes, unexplained weight loss, fever, night sweats, or fatigue. These symptoms may indicate lymphoma or other serious conditions requiring timely evaluation.

Tips for Medical Coders

Use code C83.46 for immunoblastic (diffuse) non-Hodgkin's lymphoma specifically involving intrapelvic lymph nodes. Ensure documentation supports the anatomical site and histological subtype to justify code assignment. Review clinical notes for confirmation of lymph node location and exclude other specified sites to avoid miscoding.